Parallel biochemical studies revealed that only the PI3K/AKT pathway is activated downstream of the BCR in GCB DLBCL, in contrast to ABC DLBCL where both PI3K/AKT and NF-κB are activated [86]. Here, AKT1 is linked to diffuse large B-cell lymphoma.